1
|
Lamballe F, Ahmad F, Vinik Y, Castellanet O, Daian F, Müller A, Köhler UA, Bailly A, Josselin E, Castellano R, Cayrou C, Charafe‐Jauffret E, Mills GB, Géli V, Borg J, Lev S, Maina F. Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Adv Sci (Weinh) 2021; 8:2003049. [PMID: 33552868 PMCID: PMC7856896 DOI: 10.1002/advs.202003049] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Revised: 10/12/2020] [Indexed: 05/03/2023]
Abstract
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype characterized by a remarkable molecular heterogeneity. Currently, there are no effective druggable targets and advanced preclinical models of the human disease. Here, a unique mouse model (MMTV-R26Met mice) of mammary tumors driven by a subtle increase in the expression of the wild-type MET receptor is generated. MMTV-R26Met mice develop spontaneous, exclusive TNBC tumors, recapitulating primary resistance to treatment of patients. Proteomic profiling of MMTV-R26Met tumors and machine learning approach show that the model faithfully recapitulates intertumoral heterogeneity of human TNBC. Further signaling network analysis highlights potential druggable targets, of which cotargeting of WEE1 and BCL-XL synergistically kills TNBC cells and efficiently induces tumor regression. Mechanistically, BCL-XL inhibition exacerbates the dependency of TNBC cells on WEE1 function, leading to Histone H3 and phosphoS33RPA32 upregulation, RRM2 downregulation, cell cycle perturbation, mitotic catastrophe, and apoptosis. This study introduces a unique, powerful mouse model for studying TNBC formation and evolution, its heterogeneity, and for identifying efficient therapeutic targets.
Collapse
Affiliation(s)
- Fabienne Lamballe
- Aix Marseille UnivCNRSDevelopmental Biology Institute of Marseille (IBDM)Turing Center for Living SystemsParc Scientifique de LuminyMarseille13009France
| | - Fahmida Ahmad
- Aix Marseille UnivCNRSDevelopmental Biology Institute of Marseille (IBDM)Turing Center for Living SystemsParc Scientifique de LuminyMarseille13009France
| | - Yaron Vinik
- Department of Molecular Cell BiologyWeizmann Institute of ScienceRehovot76100Israel
| | - Olivier Castellanet
- Aix Marseille UnivCNRSDevelopmental Biology Institute of Marseille (IBDM)Turing Center for Living SystemsParc Scientifique de LuminyMarseille13009France
| | - Fabrice Daian
- Aix Marseille UnivCNRSDevelopmental Biology Institute of Marseille (IBDM)Turing Center for Living SystemsParc Scientifique de LuminyMarseille13009France
| | | | - Ulrike A. Köhler
- Department of Molecular Cell BiologyWeizmann Institute of ScienceRehovot76100Israel
| | - Anne‐Laure Bailly
- Aix Marseille UnivCentre de Recherche en Cancérologie de Marseille (CRCM)Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’InsermCNRSInstitut Paoli‐CalmettesMarseille13009France
| | - Emmanuelle Josselin
- Aix Marseille UnivInsermCNRSInstitut Paoli‐CalmettesCRCMTrGET PlatformMarseille13009France
| | - Rémy Castellano
- Aix Marseille UnivInsermCNRSInstitut Paoli‐CalmettesCRCMTrGET PlatformMarseille13009France
| | - Christelle Cayrou
- Aix Marseille UnivCentre de Recherche en Cancérologie de Marseille (CRCM)Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’InsermCNRSInstitut Paoli‐CalmettesMarseille13009France
| | - Emmanuelle Charafe‐Jauffret
- Aix Marseille UnivInsermCNRSInstitut Paoli‐CalmettesCRCMExperimental Histo‐Pathology PlatformMarseille13009France
| | | | - Vincent Géli
- Aix Marseille UnivCentre de Recherche en Cancérologie de Marseille (CRCM)Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’InsermCNRSInstitut Paoli‐CalmettesMarseille13009France
| | - Jean‐Paul Borg
- Aix Marseille UnivCentre de Recherche en Cancérologie de Marseille (CRCM)Equipes labellisées Ligue ‘Cell polarity, cell signaling and cancer’ and ‘Telomere and Chromatin’InsermCNRSInstitut Paoli‐CalmettesMarseille13009France
- Institut Universitaire de France (IUF)1 rue DescartesParis75231France
| | - Sima Lev
- Department of Molecular Cell BiologyWeizmann Institute of ScienceRehovot76100Israel
| | - Flavio Maina
- Aix Marseille UnivCNRSDevelopmental Biology Institute of Marseille (IBDM)Turing Center for Living SystemsParc Scientifique de LuminyMarseille13009France
| |
Collapse
|
2
|
Routhier E, Pierre E, Khodabandelou G, Mozziconacci J. Genome-wide prediction of DNA mutation effect on nucleosome positions for yeast synthetic genomics. Genome Res 2021; 31:317-326. [PMID: 33355297 PMCID: PMC7849406 DOI: 10.1101/gr.264416.120] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 12/11/2020] [Indexed: 12/15/2022]
Abstract
Genetically modified genomes are often used today in many areas of fundamental and applied research. In many studies, coding or noncoding regions are modified in order to change protein sequences or gene expression levels. Modifying one or several nucleotides in a genome can also lead to unexpected changes in the epigenetic regulation of genes. When designing a synthetic genome with many mutations, it would thus be very informative to be able to predict the effect of these mutations on chromatin. We develop here a deep learning approach that quantifies the effect of every possible single mutation on nucleosome positions on the full Saccharomyces cerevisiae genome. This type of annotation track can be used when designing a modified S. cerevisiae genome. We further highlight how this track can provide new insights on the sequence-dependent mechanisms that drive nucleosomes' positions in vivo.
Collapse
Affiliation(s)
- Etienne Routhier
- Sorbonne Universite, CNRS, Laboratoire de Physique Théorique de la Matière Condensée, LPTMC, Paris F-75252, France
| | - Edgard Pierre
- Sorbonne Universite, CNRS, Laboratoire de Physique Théorique de la Matière Condensée, LPTMC, Paris F-75252, France
| | | | - Julien Mozziconacci
- Sorbonne Universite, CNRS, Laboratoire de Physique Théorique de la Matière Condensée, LPTMC, Paris F-75252, France
- Muséum National d'Histoire Naturelle, Structure et Instabilité des Génomes, UMR7196, Paris 75231, France
- Institut Universitaire de France, Paris 75005, France
| |
Collapse
|
3
|
Beaudoin A, Scaillet S, Mora N, Jolivet L, Augier R. In Situ and Step-Heating 40Ar/ 39Ar Dating of White Mica in Low-Temperature Shear Zones (Tenda Massif, Alpine Corsica, France). Tectonics 2020; 39:e2020TC006246. [PMID: 33380767 PMCID: PMC7756386 DOI: 10.1029/2020tc006246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Revised: 09/10/2020] [Accepted: 10/23/2020] [Indexed: 06/12/2023]
Abstract
In order to clarify the link between 40Ar/39Ar record in white mica and deformation, we performed in situ and bulkwise 40Ar/39Ar dating over the East Tenda Shear Zone (Tenda massif, Alpine Corsica). White micas from 11 samples were selected and extensively analyzed using in situ techniques across nested scales of strain-intensity gradients developed at the expense of a late-Variscan protolith. 40Ar/39Ar systematics are unaffected by inherited Ar and directly linked to deformation with little or no Ar lattice (volume) diffusion. Extensive sampling allows constraining the end of deformation related to burial and exhumation, respectively, at ~34 and ~22 Ma, bracketing the duration of regional extensional shear to ~12 Myr. Results also highlight a regional strain localization toward the upper contact of the unit with smaller-scale localization in specific lithologies, notably meta-aplites. Second-order complications exist, such as local ill-defined correlations between ages and finite-strain microstructures. Thus, the use of a strain gradient as a proxy for strain localization in time is regionally valid but sometimes locally too complex to track or resolve strain partitioning/localization trends at the meter (outcrop) scale and below. Age mixing and incomplete isotopic homogenization by dissolution/precipitation are identified as the main causes of local discrepancies that complicate the link between age and microstructure and the derivation of strain localization rates. Tracking temporal trends in shear distribution across regional-scale deformation gradients in such settings is possible but requires a multi-scale approach as implemented here to reveal younging patterns associated to strain localization.
Collapse
Affiliation(s)
- Alexandre Beaudoin
- Université d'Orléans, ISTO, UMR 7327OrléansFrance
- CNRS/INSU, ISTO, UMR 7327OrléansFrance
- BRGM, ISTO, UMR 7327OrléansFrance
| | - Stéphane Scaillet
- Université d'Orléans, ISTO, UMR 7327OrléansFrance
- CNRS/INSU, ISTO, UMR 7327OrléansFrance
- BRGM, ISTO, UMR 7327OrléansFrance
| | - Nicolas Mora
- Université d'Orléans, ISTO, UMR 7327OrléansFrance
- CNRS/INSU, ISTO, UMR 7327OrléansFrance
- BRGM, ISTO, UMR 7327OrléansFrance
| | | | - Romain Augier
- Université d'Orléans, ISTO, UMR 7327OrléansFrance
- CNRS/INSU, ISTO, UMR 7327OrléansFrance
- BRGM, ISTO, UMR 7327OrléansFrance
| |
Collapse
|
4
|
Abstract
The self-assembly of platinum complexes is a well-documented process that leads to interesting changes of the photophysical and electrochemical behavior as well as to a change in reactivity of the complexes. However, it is still not clear how many metal units must interact in order to achieve the desired properties of a large assembly. This work aimed to clarify the role of the number of interacting PtII units leading to an enhancement of the spectroscopic properties and how to address inter- versus intramolecular processes. Therefore, a series of neutral multinuclear PtII complexes were synthesized and characterized, and their photophysical properties at different concentration were studied. Going from the monomer to dimers, the growth of a new emission band and the enhancement of the emission properties were observed. Upon increasing the platinum units up to three, the monomeric blue emission could not be detected anymore and a concentration independent bright-yellow/orange emission, due to the establishment of intramolecular metallophilic interactions, was observed.
Collapse
Affiliation(s)
- Sourav Chakraborty
- Institut de Science et d'Ingénierie SupramoléculairesCNRS, UMR 7006, Université de Strasbourg8 rue Gaspard Monge67000StrasbourgFrance
| | - Alessandro Aliprandi
- Institut de Science et d'Ingénierie SupramoléculairesCNRS, UMR 7006, Université de Strasbourg8 rue Gaspard Monge67000StrasbourgFrance
| | - Luisa De Cola
- Institut de Science et d'Ingénierie SupramoléculairesCNRS, UMR 7006, Université de Strasbourg8 rue Gaspard Monge67000StrasbourgFrance
- Institute for Nanotechnology (INT)Karlsruhe Institute of TechnologyHermann-von-Helmholtz-Platz 176344Eggenstein-LeopoldshafenGermany
| |
Collapse
|
5
|
Dubois-Chevalier J, Dubois V, Dehondt H, Mazrooei P, Mazuy C, Sérandour AA, Gheeraert C, Guillaume P, Baugé E, Derudas B, Hennuyer N, Paumelle R, Marot G, Carroll JS, Lupien M, Staels B, Lefebvre P, Eeckhoute J. The logic of transcriptional regulator recruitment architecture at cis-regulatory modules controlling liver functions. Genome Res 2017; 27:985-996. [PMID: 28400425 PMCID: PMC5453331 DOI: 10.1101/gr.217075.116] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2016] [Accepted: 04/05/2017] [Indexed: 02/06/2023]
Abstract
Control of gene transcription relies on concomitant regulation by multiple transcriptional regulators (TRs). However, how recruitment of a myriad of TRs is orchestrated at cis-regulatory modules (CRMs) to account for coregulation of specific biological pathways is only partially understood. Here, we have used mouse liver CRMs involved in regulatory activities of the hepatic TR, NR1H4 (FXR; farnesoid X receptor), as our model system to tackle this question. Using integrative cistromic, epigenomic, transcriptomic, and interactomic analyses, we reveal a logical organization where trans-regulatory modules (TRMs), which consist of subsets of preferentially and coordinately corecruited TRs, assemble into hierarchical combinations at hepatic CRMs. Different combinations of TRMs add to a core TRM, broadly found across the whole landscape of CRMs, to discriminate promoters from enhancers. These combinations also specify distinct sets of CRM differentially organized along the genome and involved in regulation of either housekeeping/cellular maintenance genes or liver-specific functions. In addition to these TRMs which we define as obligatory, we show that facultative TRMs, such as one comprising core circadian TRs, are further recruited to selective subsets of CRMs to modulate their activities. TRMs transcend TR classification into ubiquitous versus liver-identity factors, as well as TR grouping into functional families. Hence, hierarchical superimpositions of obligatory and facultative TRMs bring about independent transcriptional regulatory inputs defining different sets of CRMs with logical connection to regulation of specific gene sets and biological pathways. Altogether, our study reveals novel principles of concerted transcriptional regulation by multiple TRs at CRMs.
Collapse
Affiliation(s)
- Julie Dubois-Chevalier
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Vanessa Dubois
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Hélène Dehondt
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Parisa Mazrooei
- The Princess Margaret Cancer Centre, University Health Network, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada
| | - Claire Mazuy
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Aurélien A Sérandour
- Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom
| | - Céline Gheeraert
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Penderia Guillaume
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Eric Baugé
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Bruno Derudas
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Nathalie Hennuyer
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Réjane Paumelle
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Guillemette Marot
- Université Lille, MODAL Team, Inria Lille-Nord Europe, 59650 Villeneuve-d'Ascq, France
| | - Jason S Carroll
- Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom
| | - Mathieu Lupien
- The Princess Margaret Cancer Centre, University Health Network, Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada
| | - Bart Staels
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Philippe Lefebvre
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| | - Jérôme Eeckhoute
- Université Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
| |
Collapse
|